Join the 200th Anniversary Celebration

Special Article

Use of Alternative Medicine by Women with Early-Stage Breast Cancer

Harold J. Burstein, M.D., Ph.D., Shari Gelber, M.S., Edward Guadagnoli, Ph.D., and Jane C. Weeks, M.D.

N Engl J Med 1999; 340:1733-1739June 3, 1999

Abstract

Background

We analyzed the use of alternative medicine by women who had received standard therapy for early-stage breast cancer diagnosed between September 1993 and September 1995.

Methods

A cohort of 480 patients with newly diagnosed early-stage breast cancer was recruited from a Massachusetts statewide cohort of women participating in a study of how women choose treatment for cancer. Alternative medical treatments, conventional therapies, and health-related quality of life were examined.

Results

New use of alternative medicine after surgery for breast cancer was common (reported by 28.1 percent of the women); such use was not associated with choices about standard medical therapies after we controlled for clinical and sociodemographic variables. A total of 10.6 percent of the women had used alternative medicine before they were given a diagnosis of breast cancer. Women who initiated the use of alternative medicine after surgery reported a worse quality of life than women who never used alternative medicine. Mental health scores were similar at base line among women who decided to use alternative medicine and those who did not, but three months after surgery the use of alternative medicine was independently associated with depression, fear of recurrence of cancer, lower scores for mental health and sexual satisfaction, and more physical symptoms as well as symptoms of greater intensity. All groups of women reported improving quality of life one year after surgery.

Conclusions

Among women with newly diagnosed early-stage breast cancer who had been treated with standard therapies, new use of alternative medicine was a marker of greater psychosocial distress and worse quality of life.

Media in This Article

Table 5Measures of Health-Related Quality of Life According to the Use of Alternative Medical Therapies.
Table 1Characteristics of the Study Patients and Eligible Patients Who Did Not Respond to the 12-Month Survey.
Article

Within the past 20 years, the definition of alternative medicine has come to include a variety of behavioral techniques (e.g., spiritual techniques and relaxation methods) and clinical approaches (such as massage, herbal remedies, and chiropractic) that had not previously been considered components of alternative medicine. These practices have entered mainstream society and culture; surveys now find that 30 to 40 percent of the U.S. public uses alternative medicine so defined.1-3

Retrospective or cross-sectional studies have examined the use of alternative medicine among the population at large1-3 and among patients with cancer.4-11 Collectively, these studies have established that level of income, amount of education, and age are all strongly predictive of the rate of use of alternative medicine, which includes “mind” therapies such as mental imagery, hypnosis, and relaxation and “body” therapies such as acupuncture, chiropractic, and herbal treatments. In addition, most people who use alternative medicine also see physicians.

It is not known what motivates people to use alternative medicine. The failure of standard health care, changes in the health care delivery system, patients' need for autonomy, or a preference for “holistic” or “natural” therapy, and chronic health problems have all been suggested as contributing factors.2,12-15 Cultural differences, varying beliefs about medicine,16 and the marketplace17 are also likely to affect the availability and use of alternative medicine.

The nature of the relation between alternative and standard medical treatment is unclear. Are alternative practices truly complementary to conventional care, or do they represent a substitute for standard care?18 Studies of alternative medicine have not attempted to distinguish between the widely prevalent health and lifestyle practices encompassed within alternative medicine and the initiation of these practices in response to particular changes in health.

We conducted a longitudinal study of the use of alternative medicine by a cohort of women with early-stage breast cancer. By following this population of patients, who had well-established prognoses and therapeutic options, over time, it was possible to explore the relation between alternative medicine and standard medical therapies and to examine psychological and physical factors that may contribute to the use of alternative medicine.

Methods

Patients

Subjects were recruited from among participants in a previously established, population-based study of treatment choices among women given a diagnosis of stage I or II breast cancer between September 1993 and September 1995 at randomly selected hospitals in Massachusetts.19 The characteristics of these hospitals closely paralleled those of the state as a whole. Of 1532 women potentially eligible to participate in that study, hospitals and physicians granted consent for us to contact 1158, of whom 795 (69 percent) agreed to participate. Participating hospitals were then asked to approve a protocol allowing the women in the treatment-choice study to be surveyed again about their subsequent medical care and health-related quality of life, including their use of alternative medicine. Administrative delay and lack of consent by hospitals reduced the number of women eligible for the subsequent study from 795 to 657. Of these, 536 completed a questionnaire at 3 months, and 480 ultimately completed the 12-month questionnaire, including 18 who completed the 12-month but not the 3-month questionnaire. All study analyses are limited to the 480 women (73.1 percent of the eligible participants) who completed the 12-month questionnaire. Only 5 of the 480 respondents reported a recurrence of cancer.

Collection of Data

Clinical information, including the stage of disease and the type of surgical management, was obtained from a review of medical records by an experienced data abstracter, as previously described.19 Eligible women were contacted at home by telephone by an independent research agency within 60 days after surgery. Patients who consented to participate received mailed questionnaires timed to arrive 3 months and 12 months after the initial surgery. In these questionnaires, patients reported information about their income, level of education, medical treatments, side effects of these treatments, and psychological and physical functioning. Telephone interviews were conducted with 23 of the women who did not return their questionnaires; in these interviews an abbreviated version of the mailed surveys was used.

Survey Instruments

Patients were surveyed with standard instruments for assessing physical and emotional health and quality of life, which have been widely used and validated for use with patients with breast cancer.20 Included in both the 3-month and 12-month assessments were the Medical Outcomes Study (MOS) 36-item Short-Form Health Survey (SF-36) for assessing physical and mental health (possible ranges, 8 to 73 and 10 to 74, respectively; higher scores on this scale denote better physical or mental health),21 and the MOS sexual-satisfaction survey (possible range, 0 to 100; higher scores denote greater sexual satisfaction); the latter was omitted in the 23 telephone interviews.22 We also used the depression scale of the Center for Epidemiologic Studies (CES-D) to identify depressive symptoms (possible range, 0 to 45; higher scores denote more depressive symptoms)23; a symptom checklist from the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial, expanded to 28 questions to include assessment of the potential side effects of surgery, chemotherapy, and radiation therapy, as well as other health- and cancer-related problems such as symptoms of menopause (possible range, 0 to 28; higher scores denote a greater number of symptoms), which could be weighted to account for the severity of symptoms (possible range, 0 to 112)24; and the scale of Lasry and Margolese for fear of recurrence of breast cancer after surgery (possible range, 3 to 12; higher scores denote greater fear of recurrence).25 In the three-month survey, subjects were also asked to complete the SF-36 for the month before the diagnosis of breast cancer (this information was used as a “recalled base line”).

Patients were asked about the use of alternative medicine during the previous year as part of the 12-month questionnaire only. Respondents were asked, “Have you used any of the following therapies since your breast surgery?” The list was derived from that of Eisenberg et al.1 No reference was made to such terms as “alternative” or “complementary.” Patients indicating the use of alternative medicine were asked if their doctor was aware of this use, whether insurance covered its costs, and whether they had used that type of alternative medical care in the year before breast surgery.

Analysis of Use of Alternative Medicine

For purposes of analysis, alternative medical therapies were classified in two categories: healing therapies, which required physical action on or exposure of the body (megavitamins, herbal remedies, massage, chiropractic, diet, acupuncture, energy healing, homeopathy, and folk remedies), and psychological therapies, involving primarily mental processes (relaxation, self-help groups, spiritual methods, imagery, biofeedback, and hypnosis). The use of alternative medicine was also classified as new (initiated within the year after breast surgery), continuous (used both before and after surgery), or none. In most analyses, patients who used alternative medicine were grouped into two categories: those with no use and those with any use (whether new or continuous). We combined the categories of new and continuous use because there were no statistically significant differences between them in the analyses in which they were treated separately. The only exception to this grouping (no use vs. any use) was in the analysis of mean scores on measures of health-related quality of life. Of the 480 women in the study, 135 were classified as new users, 51 as continuous users, and 294 as nonusers of alternative medicine.

Statistical Analysis

Statistical analyses were carried out with use of SAS software.26 Pearson chi-square statistics were calculated to assess the differences in characteristics between the 480 women who responded to the 12-month questionnaire and the 177 eligible women who did not. Chi-square analysis was also used to test for significant differences in the use of alternative medicine according to marital status and according to the standard treatments received. Tests for trend in ordered categorical variables were performed with use of logistic-regression modeling and stepwise selection of variables. Wilcoxon rank-sum analysis was used to compare health-related quality-of-life scores for physical and psychological function between the new users of alternative medicine and the nonusers and between the continuous users and the nonusers. Multiple comparisons in the analyses of mean scores in Table 5Table 5Measures of Health-Related Quality of Life According to the Use of Alternative Medical Therapies. were handled by means of a Bonferroni adjustment; thus, P values below 0.002 were considered to indicate statistical significance. All P values are two-sided.

Results

Characteristics of the Patients

Characteristics of the 480 participants who completed the 12-month questionnaire are shown in Table 1Table 1Characteristics of the Study Patients and Eligible Patients Who Did Not Respond to the 12-Month Survey.. There were no significant differences between these respondents and the 177 eligible women who did not complete the surveys with regard to age, marital or menopausal status, breast-cancer stage, or type of surgery (mastectomy or lumpectomy). Respondents had significantly higher levels of education and income, were more likely to be white, and had fewer coexisting illnesses. A similar analysis comparing the respondents with the remainder of the population-based cohort showed the same demographic trends and found that respondents tended to be younger (data not shown).

Alternative Medical Practices

New use of alternative medicine was common after surgery, with 135 of 480 women (28.1 percent) starting to use some type of alternative medicine (Table 2Table 2Use of Alternative Medicine among 480 Women with Early-Stage Breast Cancer.). New use accounted for over 70 percent of all use of alternative medicine (135 new users among 186 women with any use). Among the 135 patients who first used alternative medicine after breast surgery, an average of 2.5 different alternative medical practices were used. Most patients (71.0 percent) indicated that physicians were aware of their use of alternative medicine.

As shown in Table 3Table 3Relation of Socioeconomic and Demographic Characteristics to the New Use of Alternative Medical Therapies., age, marital status, education level, and income were significantly associated in univariate analyses with new use of alternative medicine. There were no qualitative differences in patterns of use between the two main categories of alternative medicine. In multivariate analyses of socioeconomic and demographic factors, including age, marital status, race, education level, and income, only younger ages and higher levels of education were significant correlates of new use of alternative medicine (P values <0.001 by logistic regression).

Association between Use of Alternative Medicine and Choice of Standard Medical Treatment

We found that women with stage II disease and those who received chemotherapy were significantly more likely to begin using alternative medicine, whereas women who were receiving tamoxifen were significantly less likely to do so (Table 4Table 4Relation of Clinical Factors to the New Use of Alternative Medical Therapies.). However, in stepwise logistic-regression analyses with adjustment for age, education level, income, marital status, and type of medical and surgical treatment, new use of alternative medicine was not associated with whether women with either stage I or II breast cancer elected to receive adjuvant therapy (chemotherapy, endocrine therapy, or both). Similarly, the decision to begin to use alternative medicine was not independently associated with whether the women underwent lumpectomy or mastectomy, or with the use or nonuse of radiation therapy.

As Table 5 shows, all groups of patients had similar base-line mental health and physical health scores. This table displays data for three categories of women: nonusers, continuous users, and new users of alternative medicine. At the three-month assessment, new users of alternative medicine had scores for mental health functioning that diverged significantly from those of patients who did not begin using alternative medicine (P≤0.001). The summary scores for new users had fallen from base line, whereas the scores for nonusers were higher than at base line. Scores for physical health remained similar in all three groups. Patients who reported new use of healing and psychological therapies also reported significantly more depression, less sexual satisfaction, greater fear of recurrence, and somatic symptoms that were significantly more numerous and severe than did women who never used alternative medicine (Table 5). At 12 months, all groups of patients had improvement in their mental health and physical health scores, although patients who had started to use an alternative psychological treatment after surgery for breast cancer still reported less sexual satisfaction and greater fear of recurrence of cancer. For many measures of the health-related quality of life, scores for continuous users were intermediate between those of new users and nonusers, though these trends did not reach required levels of statistical significance (Table 5).

To identify psychosocial factors related to the decision to use alternative medicine, logistic-regression analyses were performed with adjustment for age, education level, use or nonuse of chemotherapy, and summary scores for physical health. Higher scores for fear of recurrence (P=0.008) and depression (CES-D score ≥9, P=0.09) and a greater number of symptoms (P=0.01) were associated with the new use of psychological therapies. Similarly, worse summary scores for mental health (P=0.02) and a greater number of symptoms (P<0.001) were associated with the use of healing therapies.

Discussion

In this group of 480 women with early-stage breast cancer, the use of alternative medicine was common, and many patients began to use alternative medicine in the wake of the diagnosis of breast cancer. Alternative medicine was used along with surgery, radiation therapy, and chemotherapy, but the use of alternative medicine was not related to choices about these treatments for breast cancer. However, patients who initiated the use of alternative medicine after breast-cancer surgery reported more depression, worse general mental health, and greater fear of recurrence of the tumor than the women who were not users of alternative medicine or whose use of alternative medicine predated the diagnosis of cancer.

Patients with early-stage breast cancer have many therapeutic options and a favorable prognosis. They have considerable discretion in deciding whether to receive moderately toxic adjuvant therapies. Notably, the use of adjuvant therapy was not associated either positively or negatively with the decision to pursue alternative medicine in either stage I or stage II breast cancer. Similarly, the choice of surgical treatment and other major medical options was not associated with the use of alternative medicine. For these reasons, it appears that the patients we studied viewed “alternative” medicine as a complement to rather than an alternative to established medical practices for treating breast cancer.

New use of alternative medicine, which we identified in the cases of 135 of the 480 women, may have clinical significance as a marker of psychosocial distress after surgery for breast cancer. Women in this study cohort who started using alternative medicine reported a worse quality of life, irrespective of which standard therapies they received for breast cancer. Differences between new users of alternative medicine and other women on measures of depression, anxiety, somatic symptoms, and sexual satisfaction were most evident three months after surgery. The outcomes among users of alternative medicine reflected deterioration from base-line levels of mental health functioning. By contrast, women who did not begin using alternative medicine (whether nonusers or continuous users of such therapies) had stable or improving mental health scores. For all groups, the quality of life had improved considerably by one year after breast-cancer surgery.

Anxiety, marital strain, depression, increased symptoms, and lower levels of sexual satisfaction are common among patients with breast cancer in the year after the diagnosis.20,27-33 Women in this study who reported new use of alternative medicine were more likely to report these negative feelings and symptoms than were continuous users or nonusers. This finding raises the possibility that women may start using alternative medicine in response to psychological symptoms or distress.

Several limitations of our study must be acknowledged. An important source of potential bias is the attrition that occurred in the process of recruiting participants from the population-based cohort. Accrual was reduced by the lack of consent by the hospital or physician, administrative delay, and lack of consent or cooperation on the part of the patient. The population we investigated consisted of women who agreed to have their therapeutic choices examined and to participate in this study of their medical outcomes and quality of life. These women tended to be better educated, with higher household incomes and, aside from breast cancer, in better physical health than those who did not participate. Thus, the behavior and experiences reported by these women may not be representative of those of all women with breast cancer. Furthermore, the list of alternative medical treatments used in this study was derived from a standard work so as to facilitate comparison with other studies; it is not encyclopedic. The relations between alternative medical therapies and choices regarding standard treatments or the quality of life were similar regardless of the type or category of alternative medicine used, but a more exhaustive list of alternative therapies might have yielded different results. It is also not possible to conclude, for any given woman, what precisely motivated the use of alternative medicine. For these reasons, further studies are clearly needed.

Nonetheless, our findings may have implications for clinicians who care for patients with breast cancer. Our results suggest, first, that most patients who seek at least some of their care in traditional medical settings do not reject or forgo standard treatments for cancer in favor of alternative therapies. Second, the initiation of the use of alternative medicine should alert clinicians to inquire about anxiety, depression, or physical symptoms. Physicians who recognize this association may be afforded an opportunity to broach subjects that patients and doctors have historically been reluctant to confront. Vulnerable patients identified by the new use of alternative medicine might then benefit from programs tailored to their psychosocial and physical needs.

Supported by a grant (CA 59408) from the National Cancer Institute and by the Friends of Dana–Farber Cancer Institute.

Source Information

From the Department of Adult Oncology (H.J.B., J.C.W.) and the Center for Outcomes and Policy Research (S.G., J.C.W.), Dana–Farber Cancer Institute and Harvard Medical School; and the Department of Health Care Policy, Harvard Medical School (E.G.) — all in Boston.

Address reprint requests to Dr. Weeks at the Dana–Farber Cancer Institute, 44 Binney St., Boston, MA 02115, or at .

References

References

  1. 1

    Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-252
    Full Text | Web of Science | Medline

  2. 2

    Astin JA. Why patients use alternative medicine: results of a national study. JAMA 1998;279:1548-1553
    CrossRef | Web of Science | Medline

  3. 3

    Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280:1569-1575
    CrossRef | Web of Science | Medline

  4. 4

    Lerner IJ, Kennedy BJ. The prevalence of questionable methods of cancer treatment in the United States. CA Cancer J Clin 1992;42:181-191
    CrossRef | Web of Science | Medline

  5. 5

    Harris L. Health information and the use of questionable treatments: a study of the American public, 1987. Washington, D.C.: Department of Health and Human Services, 1987.

  6. 6

    Cassileth BR, Lusk EJ, Strouse TB, Bodenheimer BJ. Contemporary unorthodox treatments in cancer medicine: a study of patients, treatments, and practitioners. Ann Intern Med 1984;101:105-112
    Web of Science | Medline

  7. 7

    Downer SM, Cody MM, McCluskey P, et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 1994;309:86-89
    CrossRef | Web of Science | Medline

  8. 8

    Risberg T, Lund E, Wist E, Kaasa S, Wilsgaard T. Cancer patients use of nonproven therapy: a 5-year follow-up study. J Clin Oncol 1998;16:6-12
    Web of Science | Medline

  9. 9

    Crocetti E, Crotti N, Feltrin A, Ponton P, Geddes M, Buiatti E. The use of complementary therapies by breast cancer patients attending conventional treatment. Eur J Cancer 1998;34:324-328
    CrossRef | Web of Science | Medline

  10. 10

    Siegel A, Troxel A, Vahdat L. Prevalence of alternative/complementary medicine (ACM) use among breast cancer patients. Proc Am Soc Clin Oncol 1998;17:667-667 abstract.

  11. 11

    VandeCreek L, Rogers E, Lester J. Use of alternative therapies among breast cancer outpatients compared with the general population. Altern Ther Health Med 1999;5:71-76
    Web of Science | Medline

  12. 12

    Lerner IJ. The whys of cancer quackery. Cancer 1984;53:Suppl:815-819
    CrossRef | Web of Science | Medline

  13. 13

    Danielson KJ, Stewart DE, Lippert GP. Unconventional cancer remedies. CMAJ 1988;138:1005-1011
    Web of Science | Medline

  14. 14

    Cassileth BR, Chapman CC. Alternative and complementary cancer therapies. Cancer 1996;77:1026-1034
    CrossRef | Web of Science | Medline

  15. 15

    Angell M, Kassirer JP. Alternative medicine -- the risks of untested and unregulated remedies. N Engl J Med 1998;339:839-841
    Full Text | Web of Science | Medline

  16. 16

    Gevitz N. Three perspectives on unorthodox medicine. In: Gevitz N, ed. Other healers. Baltimore: Johns Hopkins University Press, 1988:1-28.

  17. 17

    Ackerman J. Alternative medicine goes mainstream. Boston Globe. April 12, 1998:E1.

  18. 18

    Coppes MJ, Anderson RA, Egeler RM, Wolff JEA. Alternative therapies for the treatment of childhood cancer. N Engl J Med 1998;339:846-846
    Full Text | Web of Science | Medline

  19. 19

    Guadagnoli E, Weeks JC, Shapiro CL, Gurwitz JH, Borbas C, Soumerai SB. Use of breast-conserving surgery for treatment of stage I and stage II breast cancer. J Clin Oncol 1998;16:101-106
    Web of Science | Medline

  20. 20

    Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol 1998;16:501-514
    Web of Science | Medline

  21. 21

    Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483
    CrossRef | Web of Science | Medline

  22. 22

    Sherbourne CD. Social functioning: sexual problems measures. In: Stewart AL, Ware JE Jr, eds. Measuring functioning and well-being: the Medical Outcomes Study approach. Durham, N.C.: Duke University Press, 1992:194-204.

  23. 23

    Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401
    CrossRef

  24. 24

    Ganz PA, Day R, Ware JE Jr, Redmond C, Fisher B. Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. J Natl Cancer Inst 1995;87:1372-1382
    CrossRef | Web of Science | Medline

  25. 25

    Lasry JCM, Margolese RG. Fear of recurrence, breast-conserving surgery, and the trade-off hypothesis. Cancer 1992;69:2111-2115
    CrossRef | Web of Science | Medline

  26. 26

    SAS/STAT user's guide, version 6. Cary, N.C.: SAS Institute, 1990.

  27. 27

    Rowland JH, Massie MJ. Psychologic reactions to breast cancer diagnosis, treatment, and survival. In: Harris JR, Lippman ME, Morrow M, Hellman S, eds. Diseases of the breast. Philadelphia: Lippincott-Raven, 1996:919-38.

  28. 28

    Meyerowitz BE, Sparks FC, Spears IK. Adjuvant chemotherapy for breast carcinoma: psychosocial implications. Cancer 1979;43:1613-1618
    CrossRef | Web of Science | Medline

  29. 29

    Taylor SE, Lichtman RR, Wood JV, Bluming AZ, Dosik G, Leibowitz RL. Illness-related and treatment-related factors in psychological adjustment to breast cancer. Cancer 1985;55:2506-2513
    CrossRef | Web of Science | Medline

  30. 30

    Mor V, Malin M, Allen S. Age differences in the psychosocial problems encountered by breast cancer patients. In: Journal of National Cancer Institute monographs. No. 16. Washington, D.C.: Government Printing Office, 1994:191-8. (NIH publication no. 93-03559.)

  31. 31

    Ganz PA, Hirji K, Sim MS, Schag CAC, Fred C, Polinsky ML. Predicting psychosocial risk in patients with breast cancer. Med Care 1993;31:419-431
    CrossRef | Web of Science | Medline

  32. 32

    Maunsell E, Brisson J, Deschenes L. Psychological distress after initial treatment of breast cancer: assessment of potential risk factors. Cancer 1992;70:120-125
    CrossRef | Web of Science | Medline

  33. 33

    Schag CAC, Ganz PA, Polinsky ML, Fred C, Hirji K, Petersen L. Characteristics of women at risk for psychosocial distress in the year after breast cancer. J Clin Oncol 1993;11:783-793
    Web of Science | Medline

Citing Articles (216)

Citing Articles

  1. 1

    , B. Thewes, P. Butow, M. L. Bell, J. Beith, R. Stuart-Harris, M. Grossi, A. Capp, D. Dalley. (2012) Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Supportive Care in Cancer
    CrossRef

  2. 2

    Bernadette Egan, Heather Gage, Jackie Hood, Karen Poole, Charlotte McDowell, Gail Maguire, Lesley Storey. (2012) Availability of complementary and alternative medicine for people with cancer in the British National Health Service: Results of a national survey. Complementary Therapies in Clinical Practice
    CrossRef

  3. 3

    Gemma Viñas, Teresa Puig, Rut Porta. (2012) Estrés oxidativo en pacientes con cáncer: dos caras de una misma moneda. Medicina Clínica
    CrossRef

  4. 4

    J. S. McLay, D. Stewart, J. George, C. Rore, S. D. Heys. (2011) Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?. European Journal of Clinical Pharmacology
    CrossRef

  5. 5

    L. L. Dawes. (2011) When Subjects Bite Back: The Bristol Cancer Help Centre Study and Increasing Consumer Involvement in UK Medical Research in the 1990s. Social History of Medicine
    CrossRef

  6. 6

    N. Klafke, J. A. Eliott, G. A. Wittert, I. N. Olver. (2011) Prevalence and predictors of complementary and alternative medicine (CAM) use by men in Australian cancer outpatient services. Annals of Oncology
    CrossRef

  7. 7

    Belinda Thewes, Phillis Butow, Robert Zachariae, Soren Christensen, Sébastien Simard, Carolyn Gotay. (2011) Fear of cancer recurrence: a systematic literature review of self-report measures. Psycho-Oncologyn/a-n/a
    CrossRef

  8. 8

    S. Schraub, S. Eav, R. Schott, E. Marx. (2011) Étude psychologique du recours aux médecines parallèles en cancérologie. Psycho-Oncologie 5:3, 157-167
    CrossRef

  9. 9

    Louiza S. Velentzis, Mohammed R. Keshtgar, Jayne V. Woodside, Anthony J. Leathem, Ann Titcomb, Katherine Anne Perkins, Monika Mazurowska, Victoria Anderson, Kayleigh Wardell, Marie M. Cantwell. (2011) Significant changes in dietary intake and supplement use after breast cancer diagnosis in a UK multicentre study. Breast Cancer Research and Treatment 128:2, 473-482
    CrossRef

  10. 10

    Mateya Trinkaus, Debika Burman, Niusha Barmala, Gary Rodin, Jennifer Jones, Christopher Lo, Camilla Zimmermann. (2011) Spirituality and use of complementary therapies for cure in advanced cancer. Psycho-Oncology 20:7, 746-754
    CrossRef

  11. 11

    Axel H. Schönthal. (2011) Adverse effects of concentrated green tea extracts. Molecular Nutrition & Food Research 55:6, 874-885
    CrossRef

  12. 12

    Yi-Hsien Lin, Jen-Hwey Chiu. (2011) Use of Chinese medicine by women with breast cancer: A nationwide cross-sectional study in Taiwan. Complementary Therapies in Medicine 19:3, 137-143
    CrossRef

  13. 13

    Limor Helpman, Sarah E. Ferguson, Melanie Mackean, Amira Rana, Lisa Le, Morven A. Atkinson, Andrew Rogerson, Helen Mackay. (2011) Complementary and Alternative Medicine Use Among Women Receiving Chemotherapy for Ovarian Cancer in 2 Patient Populations. International Journal of Gynecological Cancer 21:3, 587-593
    CrossRef

  14. 14

    Sarah M. Rausch, Frankie Winegardner, Kelly M. Kruk, Vaishali Phatak, Dietlind L. Wahner-Roedler, Brent Bauer, Ann Vincent. (2011) Complementary and alternative medicine: use and disclosure in radiation oncology community practice. Supportive Care in Cancer 19:4, 521-529
    CrossRef

  15. 15

    Alicia Morgans, Lidia Schapira. (2011) Recognizing Depression in Patients with Cancer. The Journal of Supportive Oncology 9:2, 54-58
    CrossRef

  16. 16

    Jun James Mao, Christina Shearer Palmer, Kaitlin Elizabeth Healy, Krupali Desai, Jay Amsterdam. (2011) Complementary and alternative medicine use among cancer survivors: a population-based study. Journal of Cancer Survivorship 5:1, 8-17
    CrossRef

  17. 17

    Eunyoung Kang, Eun Joo Yang, Sun-Mi Kim, Il Yong Chung, Sang Ah Han, Do-Hoon Ku, Soek-Jin Nam, Jung-Hyun Yang, Sung-Won Kim. (2011) Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study. Supportive Care in Cancer
    CrossRef

  18. 18

    Maria Hietala, Maria Henningson, Christian Ingvar, Per-Ebbe Jönsson, Carsten Rose, Helena Jernström. (2011) Natural remedy use in a prospective cohort of breast cancer patients in southern Sweden. Acta Oncologica 50:1, 134-143
    CrossRef

  19. 19

    Bridget Carmady, Caroline A Smith. (2011) Use of Chinese medicine by cancer patients: a review of surveys. Chinese Medicine 6:1, 22
    CrossRef

  20. 20

    Huiyan Ma, Catherine L Carpenter, Jane Sullivan-Halley, Leslie Bernstein. (2011) The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors - results of a prospective study. BMC Cancer 11:1, 222
    CrossRef

  21. 21

    Huiyan Ma, Jane Sullivan-Halley, Ashley W Smith, Marian L Neuhouser, Catherine M Alfano, Kathleen Meeske, Stephanie M George, Anne McTiernan, Roberta McKean-Cowdin, Kathy B Baumgartner, Rachel Ballard-Barbash, Leslie Bernstein. (2011) Estrogenic botanical supplements, health-related quality of life, fatigue, and hormone-related symptoms in breast cancer survivors: a HEAL Study report. BMC Complementary and Alternative Medicine 11:1, 109
    CrossRef

  22. 22

    Shamini Jain, Desiree Pavlik, Janet Distefan, Reverend Rosalyn L. Bruyere, Julia Acer, Rosalie Garcia, Ian Coulter, John Ives, Scott C. Roesch, Wayne Jonas, Paul J. Mills. (2011) Complementary medicine for fatigue and cortisol variability in breast cancer survivors. Cancern/a-n/a
    CrossRef

  23. 23

    Charbel Abou-Diwan, James Ritchie. 2010. Drug Interactions with Garlic and Ginger Supplements. , 333-350.
    CrossRef

  24. 24

    Simon Wein, Aaron Sulkes, Salomon Stemmer. (2010) The Oncologist's Role in Managing Depression, Anxiety, and Demoralization With Advanced Cancer. The Cancer Journal 16:5, 493-499
    CrossRef

  25. 25

    Ausanee Wanchai, Jane M. Armer, Bob R. Stewart. (2010) Complementary and Alternative Medicine Use Among Women With Breast Cancer: A Systematic Review. Clinical Journal of Oncology Nursing 14:4, E45-E55
    CrossRef

  26. 26

    Arash Asher, J. Lynn Palmer, Rajesh R. Yadav, Syed W. Yusuf, Benedict Konzen, Eduardo Bruera, Ying Guo. (2010) The Effects of a Brief Relaxation Program on Symptom Distress and Heart Rate Variability in Cancer Patients. PM&R 2:7, 636-641
    CrossRef

  27. 27

    Jui-Hua Lu, Shiow-Luan Tsay, Su-Ching Sung. (2010) Taiwanese Adult Cancer Patients' Reports of Using Complementary Therapies. Cancer Nursing 33:4, 320-326
    CrossRef

  28. 28

    C. Guethlin, H. Walach, J. Naumann, H. H. Bartsch, M. Rostock. (2010) Characteristics of cancer patients using homeopathy compared with those in conventional care: a cross-sectional study. Annals of Oncology 21:5, 1094-1099
    CrossRef

  29. 29

    Omur Karakoyun-Celik, Ilknur Gorken, Sema Sahin, Esmahan Orcin, Hilmi Alanyali, Munir Kinay. (2010) Depression and anxiety levels in woman under follow-up for breast cancer: relationship to coping with cancer and quality of life. Medical Oncology 27:1, 108-113
    CrossRef

  30. 30

    Rachelle L. McCarty, Wendy J. Weber, Beth Loots, Cora Collette Breuner, Ann Vander Stoep, Lisa Manhart, Catherine Pihoker. (2010) Complementary and Alternative Medicine Use and Quality of Life in Pediatric Diabetes. The Journal of Alternative and Complementary Medicine 16:2, 165-173
    CrossRef

  31. 31

    Leah M. Ferrucci, Beth P. Bell, Kathy B. Dhotre, M. Michele Manos, Norah A. Terrault, Atif Zaman, Rosemary C. Murphy, Grace R. VanNess, Ann R. Thomas, Stephanie R. Bialek, Mayur M. Desai, Andre N. Sofair. (2010) Complementary and Alternative Medicine Use in Chronic Liver Disease Patients. Journal of Clinical Gastroenterology 44:2, e40-e45
    CrossRef

  32. 32

    Christina Gundgaard Pedersen, Søren Christensen, Anders Bonde Jensen, Robert Zachariae. (2009) Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer. European Journal of Cancer 45:18, 3172-3181
    CrossRef

  33. 33

    Kevin D. Stein, Chiewkwei Kaw, Corinne Crammer, Ted Gansler. (2009) The role of psychological functioning in the use of complementary and alternative methods among disease-free colorectal cancer survivors. Cancer 115:S18, 4397-4408
    CrossRef

  34. 34

    Barrie R. Cassileth, Marjet Heitzer, Kathleen Wesa. (2009) The public health impact of herbs and nutritional supplements. Pharmaceutical Biology 47:8, 761-767
    CrossRef

  35. 35

    Heather Greenlee, Marilie D. Gammon, Page E. Abrahamson, Mia M. Gaudet, Mary Beth Terry, Dawn L. Hershman, Manisha Desai, Susan L. Teitelbaum, Alfred I. Neugut, Judith S. Jacobson. (2009) Prevalence and predictors of antioxidant supplement use during breast cancer treatment. Cancer 115:14, 3271-3282
    CrossRef

  36. 36

    C. L. Carpenter, P. A. Ganz, L. Bernstein. (2009) Complementary and alternative therapies among very long-term breast cancer survivors. Breast Cancer Research and Treatment 116:2, 387-396
    CrossRef

  37. 37

    E. B. Golden, P. Y. Lam, A. Kardosh, K. J. Gaffney, E. Cadenas, S. G. Louie, N. A. Petasis, T. C. Chen, A. H. Schonthal. (2009) Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 113:23, 5927-5937
    CrossRef

  38. 38

    Leah M. Ferrucci, Ruth McCorkle, Tenbroeck Smith, Kevin D. Stein, Brenda Cartmel. (2009) Factors Related to the Use of Dietary Supplements by Cancer Survivors. The Journal of Alternative and Complementary Medicine 15:6, 673-680
    CrossRef

  39. 39

    Heather Gage, Lesley Storey, Charlotte McDowell, Gail Maguire, Peter Williams, Sara Faithfull, Hilary Thomas, Karen Poole. (2009) Integrated care: Utilisation of complementary and alternative medicine within a conventional cancer treatment centre. Complementary Therapies in Medicine 17:2, 84-91
    CrossRef

  40. 40

    Piriyalux Sirisupluxana, Kasara Sripichyakan, Tipaporn Wonghongkul, Hunsa Sethabouppha, Penny F. Pierce. (2009) The meaning of complementary therapy from the perspective of Thai women with breast cancer. Nursing & Health Sciences 11:1, 64-70
    CrossRef

  41. 41

    Sung R. Kim, Tai Y. Lee, Mi S. Kim, Myoung C. Lee, Sun J. Chung. (2009) Use of complementary and alternative medicine by Korean patients with Parkinson's disease. Clinical Neurology and Neurosurgery 111:2, 156-160
    CrossRef

  42. 42

    A.-C. SVENSK, I. ÖSTER, K.E. THYME, E. MAGNUSSON, M. SJÖDIN, M. EISEMANN, S. ÅSTRÖM, J. LINDH. (2009) Art therapy improves experienced quality of life among women undergoing treatment for breast cancer: a randomized controlled study. European Journal of Cancer Care 18:1, 69-77
    CrossRef

  43. 43

    Manfred Hensel, Martin Zoz, Anthony D. Ho. (2009) Complementary and alternative medicine in patients with chronic lymphocytic leukemia. Supportive Care in Cancer 17:1, 47-52
    CrossRef

  44. 44

    Joachim Weis, Jürgen M. Giesler. (2008) Subjective dimensions of patient competence: Relationships with selected healthcare usage behaviors and general features of self-rated competence. Patient Education and Counseling 73:3, 511-518
    CrossRef

  45. 45

    H LIN, W YANG, H LEE. (2008) Traditional Chinese medicine usage among schizophrenia patients. Complementary Therapies in Medicine 16:6, 336-342
    CrossRef

  46. 46

    Silvia Menéndez, Janet Cepero, Luis Borrego. (2008) Ozone Therapy in Cancer Treatment: State of the Art. Ozone: Science & Engineering 30:6, 398-404
    CrossRef

  47. 47

    Deborah Fellowes, Kelly Barnes, Susie SM Wilkinson, Jessica R Thomas. 2008. Aromatherapy and massage for symptom relief in patients with cancer. .
    CrossRef

  48. 48

    Agnete Egilsdatter Kristoffersen, Vinjar Fønnebø, Arne Johan Norheim. (2008) Use of Complementary and Alternative Medicine Among Patients: Classification Criteria Determine Level of Use. The Journal of Alternative and Complementary Medicine 14:8, 911-919
    CrossRef

  49. 49

    Zhi Chen, Kai Gu, Ying Zheng, Wei Zheng, Wei Lu, Xiao Ou Shu. (2008) The Use of Complementary and Alternative Medicine Among Chinese Women with Breast Cancer. The Journal of Alternative and Complementary Medicine 14:8, 1049-1055
    CrossRef

  50. 50

    Young-Hee Yom, Kyu Eun Lee. (2008) A comparison of the knowledge of, experience with and attitudes towards complementary and alternative medicine between nurses and patients in Korea. Journal of Clinical Nursing 17:19, 2565-2572
    CrossRef

  51. 51

    Keith I. Block, Amanda C. Koch, Mark N. Mead, Peter K. Tothy, Robert A. Newman, Charlotte Gyllenhaal. (2008) Impact of antioxidant supplementation on chemotherapeutic toxicity: A systematic review of the evidence from randomized controlled trials. International Journal of Cancer 123:6, 1227-1239
    CrossRef

  52. 52

    Carlo PIRRI, Paul KATRIS, James TROTTER, Evan BAYLISS, Robert BENNETT, Peter DRUMMOND. (2008) Use of complementary and alternative therapies by Western Australian cancer patients. Asia-Pacific Journal of Clinical Oncology 4:3, 161-169
    CrossRef

  53. 53

    S. WILKINSON, S. FARRELLY, J. LOW, A. CHAKRABORTY, R. WILLIAMS, S. WILKINSON. (2008) The use of complementary therapy by men with prostate cancer in the UK. European Journal of Cancer Care 17:5, 492-499
    CrossRef

  54. 54

    Weidong Lu, Elizabeth Dean-Clower, Anne Doherty-Gilman, David S. Rosenthal. (2008) The Value of Acupuncture in Cancer Care. Hematology/Oncology Clinics of North America 22:4, 631-648
    CrossRef

  55. 55

    Jun J. Mao, Steve C. Palmer, Joseph B. Straton, Peter F. Cronholm, Shimrit Keddem, Kathryn Knott, Marjorie A. Bowman, Frances K. Barg. (2008) Cancer survivors with unmet needs were more likely to use complementary and alternative medicine. Journal of Cancer Survivorship 2:2, 116-124
    CrossRef

  56. 56

    Daniel A. Monti, Meryl Sufian, Caroline Peterson. (2008) Potential role of mind-body therapies in cancer survivorship. Cancer 112:S11, 2607-2616
    CrossRef

  57. 57

    Ikuko Kato, Anne Victoria Neale. (2008) Does use of alternative medicine delay treatment of head and neck cancer? A surveillance, epidemiology, and end results (SEER) cancer registry study. Head & Neck 30:4, 446-454
    CrossRef

  58. 58

    Fuschia M. Sirois. (2008) Provider-based complementary and alternative medicine use among three chronic illness groups: Associations with psychosocial factors and concurrent use of conventional health-care services. Complementary Therapies in Medicine 16:2, 73-80
    CrossRef

  59. 59

    Doreen Oneschuk, Jawaid Younus. (2008) Natural health products and cancer chemotherapy and radiation therapy. Oncology Reviews 1:4, 233-242
    CrossRef

  60. 60

    O. Micke, J. Büntzel. (2008) Komplementäre und alternative Medizin bei Tumorpatienten. Der Onkologe 14:1, 73-80
    CrossRef

  61. 61

    Do Yeun Kim, Bong-Seog Kim, Kyung Hee Lee, Myung Ah Lee, Young Seon Hong, Sang Won Shin, Soon Nam Lee. (2008) Discrepant Views of Korean Medical Oncologists and Cancer Patients on Complementary and Alternative Medicine. Cancer Research and Treatment 40:2, 87
    CrossRef

  62. 62

    L. SALMENPERÄ. (2008) The use of complementary therapies among breast and prostate cancer patients in Finland. European Journal of Cancer Care 11:1, 44
    CrossRef

  63. 63

    Machaon Bonafede, Andrew Dick, Katia Noyes, Jonathan D. Klein, Theodore Brown. (2008) The Effect of Acupuncture Utilization on Healthcare Utilization. Medical Care 46:1, 41-48
    CrossRef

  64. 64

    Susan F. Sencer, Kara M. Kelly. (2007) Complementary and Alternative Therapies in Pediatric Oncology. Pediatric Clinics of North America 54:6, 1043-1060
    CrossRef

  65. 65

    Daniel Hollenberg, Bonnie Cowan, Noel Wright. (2007) New and Uncharted Territory: Integrative Medicine in the Medical Radiation Sciences. Canadian Journal of Medical Radiation Technology 38:4, 23-30
    CrossRef

  66. 66

    Clare Miles, Bridget Candy, Louise Jones, Rachael Williams, Adrian Tookman, Michael King, Bridget Candy. 2007. Interventions for sexual dysfunction following treatments for cancer. .
    CrossRef

  67. 67

    P. A. Fasching, F. Thiel, K. Nicolaisen-Murmann, C. Rauh, J. Engel, M. P. Lux, M. W. Beckmann, M. R. Bani. (2007) Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Supportive Care in Cancer 15:11, 1277-1284
    CrossRef

  68. 68

    C. A. K. Y. Chong, N. Diaz-Granados, G. A. Hawker, S. Jamal, R. G. Josse, A. M. Cheung. (2007) Complementary and alternative medicine use by osteoporosis clinic patients. Osteoporosis International 18:11, 1547-1556
    CrossRef

  69. 69

    M. ARMAN, M. BACKMAN. (2007) A longitudinal study on women?s experiences of life with breast cancer in anthroposophical (complementary) and conventional care. European Journal of Cancer Care 16:5, 444-450
    CrossRef

  70. 70

    Keith I. Block, Amanda C. Koch, Mark N. Mead, Peter K. Tothy, Robert A. Newman, Charlotte Gyllenhaal. (2007) Impact of antioxidant supplementation on chemotherapeutic efficacy: A systematic review of the evidence from randomized controlled trials. Cancer Treatment Reviews 33:5, 407-418
    CrossRef

  71. 71

    Alicia K. Matthews, Sarah A. Sellergren, Dezheng Huo, Marcy List, Gini Fleming. (2007) Complementary and Alternative Medicine Use Among Breast Cancer Survivors. The Journal of Alternative and Complementary Medicine 13:5, 555-562
    CrossRef

  72. 72

    Kazuo Yamada. (2007) Low level of quality of life in patients with mental and behavioral disorders wanting complementary and alternative (kampo) therapy. Quality of Life Research 16:5, 787-792
    CrossRef

  73. 73

    Catalina Lawsin, Katherine DuHamel, Steven H. Itzkowitz, Karen Brown, Helen Lim, Linda Thelemaque, Lina Jandorf. (2007) Demographic, medical, and psychosocial correlates to CAM use among survivors of colorectal cancer. Supportive Care in Cancer 15:5, 557-564
    CrossRef

  74. 74

    A. MONTAZERI, A. SAJADIAN, M. EBRAHIMI, S. HAGHIGHAT, I. HARIRCHI. (2007) Factors predicting the use of complementary and alternative therapies among cancer patients in Iran. European Journal of Cancer Care 16:2, 144-149
    CrossRef

  75. 75

    Jost Langhorst, Inga B. Anthonisen, Ulf Steder-Neukamm, Rainer Luedtke, Guenther Spahn, Andreas Michalsen, Gustav J. Dobos. (2007) Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: Perceived stress is a potential indicator for CAM use. Complementary Therapies in Medicine 15:1, 30-37
    CrossRef

  76. 76

    Jun J. Mao, John T. Farrar, Sharon X. Xie, Marjorie A. Bowman, Katrina Armstrong. (2007) Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. Complementary Therapies in Medicine 15:1, 21-29
    CrossRef

  77. 77

    Sandra A. Norman, Sheryl L. Potashnik, Mary Lou Galantino, Angela M. De Michele, Lauren House, A. Russell Localio. (2007) Modifiable Risk Factors for Breast Cancer Recurrence: What Can We Tell Survivors?. Journal of Women's Health 16:2, 177-190
    CrossRef

  78. 78

    PEETER KARIHTALA, YLERMI SOINI. (2007) Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies.. APMIS 115:2, 81-103
    CrossRef

  79. 79

    Raphael J. Leo, Jesus Salvador A. Ligot. (2007) A systematic review of randomized controlled trials of acupuncture in the treatment of depression. Journal of Affective Disorders 97:1-3, 13-22
    CrossRef

  80. 80

    Marjorie Wells, Linda Sarna, Mary E. Cooley, Jean K. Brown, Cynthia Chernecky, Roma D. Williams, Geraldine Padilla, Leda Layo Danao. (2007) Use of Complementary and Alternative Medicine Therapies to Control Symptoms in Women Living With Lung Cancer. Cancer Nursing 30:1, 45-55
    CrossRef

  81. 81

    Suzanna M. Zick, Ananda Sen, Yang Feng, Jen Green, Shade Olatunde, Heather Boon. (2006) Trial of Essiac to Ascertain Its Effect in Women with Breast Cancer (TEA-BC). The Journal of Alternative and Complementary Medicine 12:10, 971-980
    CrossRef

  82. 82

    Richard F. Branda, Cheryl Powden, Elice M. Brooks, Zafer Yildirim, Shelly J. Naud, John J. McCormack. (2006) Vitamin E but not St. John’s wort mitigates leukopenia caused by cancer chemotherapy in rats. Translational Research 148:6, 315-324
    CrossRef

  83. 83

    Brian D. Lawenda. (2006) Integrative Oncology. The Cancer Journal 12:6, 455-458
    CrossRef

  84. 84

    Catherine Buettner, Candyce H. Kroenke, Russell S. Phillips, Roger B. Davis, David M. Eisenberg, Michelle D. Holmes. (2006) Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses’ health study. Breast Cancer Research and Treatment 100:2, 219-227
    CrossRef

  85. 85

    Anu B. Swarup, William Barrett, Abdul Rahman Jazieh. (2006) The Use of Complementary and Alternative Medicine By Cancer Patients Undergoing Radiation Therapy. American Journal of Clinical Oncology 29:5, 468-473
    CrossRef

  86. 86

    Greg E. Davis, Chris L. Bryson, Bevan Yueh, Mary B. McDonell, Mark A. Micek, Stephan D. Fihn. (2006) Treatment delay associated with alternative medicine use among veterans with head and neck cancer. Head & Neck 28:10, 926-931
    CrossRef

  87. 87

    Kazuo Yamada. (2006) Quality of Life in Patients Treated with Kampo Medicine: A Complementary Alternative to Modern Medicine. The Journal of Alternative and Complementary Medicine 12:8, 799-803
    CrossRef

  88. 88

    C. J. Chang, J. H. Chiu, L. M. Tseng, C. H. Chang, T. M. Chien, C. W. Wu, W. Y. Lui. (2006) Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells. European Journal of Clinical Investigation 36:8, 588-596
    CrossRef

  89. 89

    Arsham Alamian, Isabelle Rouleau, Jacques Simard, Michel Dorval. (2006) Use of Dietary Supplements Among Women at High Risk of Hereditary Breast and Ovarian Cancer (HBOC) Tested for Cancer Susceptibility. Nutrition and Cancer 54:2, 157-165
    CrossRef

  90. 90

    Susan D. Block. (2006) Psychological Issues in End-of-Life Care. Journal of Palliative Medicine 9:3, 751-772
    CrossRef

  91. 91

    Minhee Cho, Xioabu Ye, Adrian Dobs, Joseph Cofrancesco. (2006) Prevalence of Complementary and Alternative Medicine Use Among HIV Patients for Perceived Lipodystrophy. The Journal of Alternative and Complementary Medicine 12:5, 475-482
    CrossRef

  92. 92

    L. V. Poll-Franse, F. Mols, A. J. J. M. Vingerhoets, A. C. Voogd, R. M. H. Roumen, J. W. W. Coebergh. (2006) Increased health care utilisation among 10-year breast cancer survivors. Supportive Care in Cancer 14:5, 436-443
    CrossRef

  93. 93

    (2006) Commonly used herbal medicines in the treatment for female reproductive dysfunction. Oriental Pharmacy and Experimental Medicine 6:1, 1-11
    CrossRef

  94. 94

    A. MOLASSIOTIS, G. OZDEN, N. PLATIN, J.A. SCOTT, D. PUD, P. FERNANDEZ-ORTEGA, L. MILOVICS, V. PANTELI, G. GUDMUNDSDOTTIR, M. BROWALL, E. MADSEN, E. PATIRAKI, N. KEARNEY. (2006) Complementary and alternative medicine use in patients with head and neck cancers in Europe. European Journal of Cancer Care 15:1, 19-24
    CrossRef

  95. 95

    Raquel Gerson-Cwillich, Alberto Serrano-Olvera, Alberto Villalobos-Prieto. (2006) Complementary and alternative medicine (CAM) in Mexican patients with cancer. Clinical and Translational Oncology 8:3, 200-207
    CrossRef

  96. 96

    (2006) Combined utilization with herbal products and prescribed drugs: A result from health examinee-based national survey. Korean Journal of Health Policy and Administration 16:1, 1-16
    CrossRef

  97. 97

    Sharon L. Kozachik, Gwen Wyatt, Charles W. Given, Barbara A. Given. (2006) Patterns of Use of Complementary Therapies Among Cancer Patients and Their Family Caregivers. Cancer Nursing 29:2, 84-94
    CrossRef

  98. 98

    Maria Arman, Marie Backman, Marianne Carlsson, Elisabeth Hamrin. (2006) Women's Perceptions and Beliefs About the Genesis of Their Breast Cancer. Cancer Nursing 29:2, 142-148
    CrossRef

  99. 99

    Alexander Molassiotis, Julia A. Scott, Nora Kearney, Dorit Pud, Miriam Magri, Sarka Selvekerova, Ingrid Bruyns, Paz Fernadez-Ortega, Vassiliki Panteli, Anita Margulies, Gudbjorg Gudmundsdottir, Ljiljana Milovics, Gulten Ozden, Nurgun Platin, Elisabeth Patiraki. (2006) Complementary and alternative medicine use in breast cancer patients in Europe. Supportive Care in Cancer 14:3, 260-267
    CrossRef

  100. 100

    Eran Ben-Arye, Gil Bar-Sela, Moshe Frenkel, Abraham Kuten, Doron Hermoni. (2006) Is a biopsychosocial–spiritual approach relevant to cancer treatment? A study of patients and oncology staff members on issues of complementary medicine and spirituality. Supportive Care in Cancer 14:2, 147-152
    CrossRef

  101. 101

    L. LANGMEAD, D. S. RAMPTON. (2006) Review article: complementary and alternative therapies for inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 23:3, 341-349
    CrossRef

  102. 102

    Christopher G. Lis, Jerrilyn A. Cambron, James F. Grutsch, Joel Granick, Digant Gupta. (2006) Self-reported quality of life in users and nonusers of dietary supplements in cancer. Supportive Care in Cancer 14:2, 193-199
    CrossRef

  103. 103

    Huk Jun Chung, Mee Ra Kim, Ja Seong Bae, Woo Chan Park, Byung Joo Song, Jung Soo Kim, Sang Seol Jung. (2006) Complementary and Alternative Medicine in Patients with Breast Cancer. Journal of Breast Cancer 9:4, 361
    CrossRef

  104. 104

    A MOLASSIOTIS, P FERNANDEZORTEGA, D PUD, G OZDEN, N PLATIN, S HUMMERSTON, J SCOTT, V PANTELI, G GUDMUNDSDOTTIR, S SELVEKEROVA. (2005) Complementary and alternative medicine use in colorectal cancer patients in seven European countries. Complementary Therapies in Medicine 13:4, 251-257
    CrossRef

  105. 105

    Kenneth A. Kobak, Leslie V. H. Taylor, Alexander Bystritsky, Cary J. Kohlenberg, John H. Greist, Phebe Tucker, Gemma Warner, Rise Futterer, Tanya Vapnik. (2005) St John??s wort versus placebo in obsessive???compulsive disorder: results from a double-blind study. International Clinical Psychopharmacology 20:6, 299-304
    CrossRef

  106. 106

    Elsbeth Voogt, Anna F. Leeuwen, Adriaan P. Visser, Agnes Heide, Paul J. Maas. (2005) Information needs of patients with incurable cancer. Supportive Care in Cancer 13:11, 943-948
    CrossRef

  107. 107

    Digant Gupta, Christopher G. Lis, Timothy C. Birdsall, James F. Grutsch. (2005) The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care. Supportive Care in Cancer 13:11, 912-919
    CrossRef

  108. 108

    Ignacio Correa-Velez, Alexandra Clavarino, Heather Eastwood. (2005) Surviving, Relieving, Repairing, and Boosting Up: Reasons for Using Complementary/Alternative Medicine among Patients with Advanced Cancer: A Thematic Analysis. Journal of Palliative Medicine 8:5, 953-961
    CrossRef

  109. 109

    Vedat Isikhan, Seref Komurcu, Ahmet Ozet, Fikret Arpaci, Bekir Ozturk, Oner Balbay, Perihan Guner. (2005) The Status of Alternative Treatment in Cancer Patients in Turkey. Cancer Nursing 28:5, 355-362
    CrossRef

  110. 110

    Koji Yoshimura, Nobufumi Ueda, Kentaro Ichioka, Yoshiyuki Matsui, Akito Terai, Yoichi Arai. (2005) Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution. Supportive Care in Cancer 13:9, 685-690
    CrossRef

  111. 111

    Weidong Lu. (2005) Acupuncture for Side Effects of Chemoradiation Therapy in Cancer Patients. Seminars in Oncology Nursing 21:3, 190-195
    CrossRef

  112. 112

    Dominique Martel, Jean-François Bussières, Yves Théorêt, Denis Lebel, Sandra Kish, Albert Moghrabi, Claudine Laurier. (2005) Use of alternative and complementary therapies in children with cancer. Pediatric Blood & Cancer 44:7, 660-668
    CrossRef

  113. 113

    Ali Montazeri, Akram Sajadian, Mandana Ebrahimi, Mohammad Esmail Akbari. (2005) Depression and the use of complementary medicine among breast cancer patients. Supportive Care in Cancer 13:5, 339-342
    CrossRef

  114. 114

    Sophie Lauzier, Elizabeth Maunsell, Maria De Koninck, Mélanie Drolet, Nicole Hébert-Croteau, Jean Robert. (2005) Conceptualization and sources of costs from breast cancer: Findings from patient and caregiver focus groups. Psycho-Oncology 14:5, 351-360
    CrossRef

  115. 115

    ALICIA K. MATTHEWS, TONDA L. HUGHES, GAIL PINALES OSTERMAN, MOLLY M. KODL. (2005) Complementary Medicine Practices in a Community-Based Sample of Lesbian and Heterosexual Women. Health Care for Women International 26:5, 430-447
    CrossRef

  116. 116

    Sara Rockwell, Yanfeng Liu, Susan A. Higgins. (2005) Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh. Breast Cancer Research and Treatment 90:3, 233-239
    CrossRef

  117. 117

    P. P. Roy-Byrne. (2005) Use of Herbal Medicine in Primary Care Patients With Mood and Anxiety Disorders. Psychosomatics 46:2, 117-122
    CrossRef

  118. 118

    Eileen Rakovitch, Jean-Philippe Pignol, Carole Chartier, Michelle Ezer, Sunil Verma, George Dranitsaris, Mark Clemons. (2005) Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Research and Treatment 90:2, 139-148
    CrossRef

  119. 119

    Mário L. De Lemos. (2005) Pharmacist's role in meeting the psychosocial needs of cancer patients using complementary therapy. Psycho-Oncology 14:3, 204-210
    CrossRef

  120. 120

    Robin Davidson, Laura Geoghegan, Lynne Mclaughlin, Roger Woodward. (2005) Psychological characteristics of cancer patients who use complementary therapies. Psycho-Oncology 14:3, 187-195
    CrossRef

  121. 121

    Jost Langhorst, Inga B Anthonisen, Ulf Steder-Neukamm, Rainer Lüdtke, Guenther Spahn, Andreas Michalsen, Gustav J Dobos. (2005) Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease. Results From a German National Survey. Inflammatory Bowel Diseases 11:3, 287-295
    CrossRef

  122. 122

    Nagi B Kumar. (2005) Green Tea Polyphenols. Evidence-Based Integrative Medicine 2:1, 13-18
    CrossRef

  123. 123

    &NA;. (2004) Hippocratic Oath. Southern Medical Journal 97:12, 1169
    CrossRef

  124. 124

    Sara L. Swenson, Stephanie Buell, Patti Zettler, Martha White, Delaney C. Ruston, Bernard Lo. (2004) Patient-centered Communication. Do Patients Really Prefer It?. Journal of General Internal Medicine 19:11, 1069-1079
    CrossRef

  125. 125

    Karen P. L. Yap, David R. McCready, Anthony Fyles, Lee Manchul, Maureen Trudeau, Steven Narod. (2004) Use of Alternative Therapy in Postmenopausal Breast Cancer Patients Treated with Tamoxifen after Surgery. The Breast Journal 10:6, 481-486
    CrossRef

  126. 126

    G. Nagel, H. Hoyer, D. Katenkamp. (2004) Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey. Supportive Care in Cancer 12:11, 789-796
    CrossRef

  127. 127

    Suzanne K. Steginga, Stefano Occhipinti, R.A.(Frank) Gardiner, John Yaxley, Peter Heathcote. (2004) A prospective study of the use of alternative therapies by men with localized prostate cancer. Patient Education and Counseling 55:1, 70-77
    CrossRef

  128. 128

    Jim Lemon, Sarah Edelman, Antony D. Kidman. (2004) Perceptions of the “Mind-Cancer” Relationship Among the Public, Cancer Patients, and Oncologists. Journal of Psychosocial Oncology 21:4, 43-58
    CrossRef

  129. 129

    D Fellowes, K Barnes, S Wilkinson, Deborah Fellowes. 2004. Aromatherapy and massage for symptom relief in patients with cancer. .
    CrossRef

  130. 130

    Sung W. Lee, Carol A. Mancuso, Mary E. Charlson. (2004) Prospective Study of New Participants in a Community-based Mind-body Training Program. Journal of General Internal Medicine 19:7, 760-765
    CrossRef

  131. 131

    Yong Cui, Xiao-Ou Shu, Yutang Gao, Wanqing Wen, Zhi-Xian Ruan, Fan Jin, Wei Zheng. (2004) Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Research and Treatment 85:3, 263-270
    CrossRef

  132. 132

    Prasad S. Adusumilli, Leah Ben-Porat, Meriner Pereira, Daniel Roesler, I.Michael Leitman. (2004) The prevalence and predictors of herbal medicine use in surgical patients1 1No competing interests declared.. Journal of the American College of Surgeons 198:4, 583-590
    CrossRef

  133. 133

    William E. Lafferty, Allen Bellas, Andrea Corage Baden, Patrick Timothy Tyree, Leanna J. Standish, Ruth Patterson. (2004) The use of complementary and alternative medical providers by insured cancer patients in Washington state. Cancer 100:7, 1522-1530
    CrossRef

  134. 134

    Martine Spence, Peter Ribeaux. (2004) Complementary and alternative medicine: Consumers in search of wellness or an expression of need by the sick?. Psychology and Marketing 21:2, 113-139
    CrossRef

  135. 135

    Subhas C. Ganguli, Ruth Cawdron, E.J. Irvine. (2004) Alternative Medicine Use by Canadian Ambulatory Gastroenterology Patients: Secular Trend or Epidemic?. The American Journal of Gastroenterology 99:2, 319-326
    CrossRef

  136. 136

    Maurie Markman. (2004) Is it time for oncologists to modify their laissez-faire attitude toward alternative/ complementary ‘drug therapy’?. Current Oncology Reports 6:1, 1-2
    CrossRef

  137. 137

    Suzanna M Zick. (2004) Association between Physical Functional Limitations and Visiting a Complementary and Alternative Medicine Provider. Evidence-Based Integrative Medicine 1:3, 203-208
    CrossRef

  138. 138

    Michael S. Goldstein. (2003) Complementary and Alternative Medicine. Journal of Psychosocial Oncology 21:2, 1-21
    CrossRef

  139. 139

    Helen R. Winefield, Brendon J. Coventry, Meg Lewis, Eileen J. Harvey. (2003) Attitudes of Patients with Breast Cancer Toward Support Groups. Journal of Psychosocial Oncology 21:2, 39-54
    CrossRef

  140. 140

    Jaya K. Rao, Kurt Kroenke, Kimberly A. Mihaliak, Steven C. Grambow, Morris Weinberger. (2003) Rheumatology patients' use of complementary therapies: Results from a one-year longitudinal study. Arthritis & Rheumatism 49:5, 619-625
    CrossRef

  141. 141

    Edzard Ernst. (2003) Complementary therapies for cancer, more good than harm?. Wiener Klinische Wochenschrift 115:19-20, 676-677
    CrossRef

  142. 142

    Linda J. Edgar, Jean Remmer, Zeev Rosberger, Bruce Rapkin. (2003) Evaluating a Volunteer Cancer Support Service. Journal of Psychosocial Oncology 21:1, 53-72
    CrossRef

  143. 143

    J. ENGEL, J. KERR, A. SCHLESINGER-RAAB, R. ECKEL, H. SAUER, D. HÖLZEL. (2003) Comparison of breast and rectal cancer patients’ quality of life: results of a four year prospective field study. European Journal of Cancer Care 12:3, 215-223
    CrossRef

  144. 144

    ZEINA NAHLEH, IMAD A. TABBARA. (2003) Complementary and alternative medicine in breast cancer patients. Palliative & Supportive Care 1:03,
    CrossRef

  145. 145

    Yu-Fu Chen, Jeffrey S. Chang. (2003) Complementary and alternative medicine use among patients attending a hospital dermatology clinic in Taiwan. International Journal of Dermatology 42:8, 616-621
    CrossRef

  146. 146

    Elizabeth M. Gagnon, Christopher J. Recklitis. (2003) Parents' decision-making preferences in pediatric oncology: The relationship to health care involvement and complementary therapy use. Psycho-Oncology 12:5, 442-452
    CrossRef

  147. 147

    MICHAEL A. DIEFENBACH, NATALIE HAMRICK, ROBERT UZZO, ALAN POLLACK, ERIC HORWITZ, RICHARD GREENBERG, PAUL F. ENGSTROM. (2003) Clinical, Demographic and Psychosocial Correlates of Complementary and Alternative Medicine Use by Men Diagnosed With Localized Prostate Cancer. The Journal of Urology 170:1, 166-169
    CrossRef

  148. 148

    David W. Ramey. (2003) Regulatory aspects of complementary and alternative veterinary medicine. Journal of the American Veterinary Medical Association 222:12, 1679-1682
    CrossRef

  149. 149

    Myles N. Sheehan. (2003) Spirituality and Medicine. Journal of Palliative Medicine 6:3, 429-431
    CrossRef

  150. 150

    Bernadette Marriott. 2003. An introduction to dietary supplements of plant origin. , 1-17.
    CrossRef

  151. 151

    Helen R. Winefield, Brendon J. Coventry, Malcolm Pradhan, Eileen Harvey, Vanessa Lambert. (2003) A Comparison of Women with Breast Cancer who Do and Do Not Seek Support from the Internet. Australian Journal of Psychology 55:1, 30-34
    CrossRef

  152. 152

    Joanne Barnes. (2003) Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality. British Journal of Clinical Pharmacology 55:3, 226-233
    CrossRef

  153. 153

    Ruth E Patterson, Marian L Neuhouser, Monique M Hedderson, Stephen M Schwartz, Leanna J Standish, Deborah J Bowen. (2003) Changes in diet, physical activity, and supplement use among adults diagnosed with cancer. Journal of the American Dietetic Association 103:3, 323-328
    CrossRef

  154. 154

    Ioana Bica, Alice M. Tang, Sarah Skinner, Donna Spiegelman, Tamsin Knox, Sherwood Gorbach, Ira B. Wilson. (2003) Use of Complementary and Alternative Therapies by Patients With Human Immunodeficiency Virus Disease in the Era of Highly Active Antiretroviral Therapy. The Journal of Alternative and Complementary Medicine 9:1, 65-76
    CrossRef

  155. 155

    Erica S Breslau. 2003. THE CONTINUUM: SOMATIC DISTRESS TO MEDICALIZATION IN WOMEN WITH BREAST CANCER: THEORETICAL AND EMPIRICAL ASSESSMENT. , 131-180.
    CrossRef

  156. 156

    Jessica W. Henderson, Rebecca J. Donatelle. (2003) The relationship between cancer locus of control and complementary and alternative medicine use by women diagnosed with breast cancer. Psycho-Oncology 12:1, 59-67
    CrossRef

  157. 157

    SIMON WILKINSON, LEONARD G. GOMELLA, JOSEPH A. SMITH, MICHAEL K. BRAWER, NANCY A. DAWSON, ZEV WAJSMAN, LANTING DAI, GERALD W. CHODAK. (2002) Attitudes and Use of Complementary Medicine in Men with Prostate Cancer. The Journal of Urology2505-2509
    CrossRef

  158. 158

    SIMON WILKINSON, LEONARD G. GOMELLA, JOSEPH A. SMITH, MICHAEL K. BRAWER, NANCY A. DAWSON, ZEV WAJSMAN, LANTING DAI, GERALD W. CHODAK. (2002) Attitudes and Use of Complementary Medicine in Men with Prostate Cancer. The Journal of Urology 168:6, 2505-2509
    CrossRef

  159. 159

    Dianne M. Shumay, Gertraud Maskarinec, Carolyn C. Gotay, Elaine M. Heiby, Hisako Kakai. (2002) Determinants of the Degree of Complementary and Alternative Medicine Use Among Patients with Cancer. The Journal of Alternative and Complementary Medicine 8:5, 661-671
    CrossRef

  160. 160

    Jeffrey D. White. (2002) The National Cancer Institute's Perspective and Agenda for Promoting Awareness and Research on Alternative Therapies for Cancer. The Journal of Alternative and Complementary Medicine 8:5, 545-550
    CrossRef

  161. 161

    M. M. Lee, J. S. Chang, B. Jacobs, M. R. Wrensch. (2002) Complementary and Alternative Medicine Use Among Men With Prostate Cancer in 4 Ethnic Populations. American Journal of Public Health 92:10, 1606-1609
    CrossRef

  162. 162

    Bernardine M. Pinto, Joseph J. Trunzo, Philip Reiss, Shang-Ying Shiu. (2002) Exercise participation after diagnosis of breast cancer: trends and effects on mood and quality of life. Psycho-Oncology 11:5, 389-400
    CrossRef

  163. 163

    Fuschia M Sirois, Mary L Gick. (2002) An investigation of the health beliefs and motivations of complementary medicine clients. Social Science & Medicine 55:6, 1025-1037
    CrossRef

  164. 164

    Ruth E. Patterson, Marian L. Neuhouser, Monique M. Hedderson, Stephen M. Schwartz, Leanna J. Standish, Deborah J. Bowen, Lynn M. Marshall. (2002) Types of Alternative Medicine Used by Patients with Breast, Colon, or Prostate Cancer: Predictors, Motives, and Costs. The Journal of Alternative and Complementary Medicine 8:4, 477-485
    CrossRef

  165. 165

    Joel Mason, Sang-Woon Choi. 2002. Nutritional Assessment and Management of the Cancer Patient. , 197-224.
    CrossRef

  166. 166

    Marja J. Verhoef, Margaret A. White. (2002) Factors in Making the Decision to Forgo Conventional Cancer Treatment. Cancer Practice 10:4, 201-207
    CrossRef

  167. 167

    Patricia F. Harris, Patrick L. Remington, Amy Trentham-Dietz, Catherine I. Allen, Polly A. Newcomb. (2002) Prevalence and Treatment of Menopausal Symptoms Among Breast Cancer Survivors. Journal of Pain and Symptom Management 23:6, 501-509
    CrossRef

  168. 168

    Louise Langmead, Meenali Chitnis, David S. Rampton. (2002) Use of Complementary Therapies by Patients with IBD May Indicate Psychosocial Distress. Inflammatory Bowel Diseases 8:3, 174-179
    CrossRef

  169. 169

    Mary Jane Ott. (2002) Complementary and Alternative Therapies in Cancer Symptom Management. Cancer Practice 10:3, 162-166
    CrossRef

  170. 170

    Antònia Bassols, Fèlix Bosch, Josep-Eladi Baños. (2002) How Does the General Population Treat Their Pain? A Survey in Catalonia, Spain. Journal of Pain and Symptom Management 23:4, 318-328
    CrossRef

  171. 171

    Prasad S Adusumilli, Byrne Lee, Kalpaj Parekh, Patricia A Farrelly. (2002) Acalculous eosinophilic cholecystitis from herbal medicine: A review of adverse effects of herbal medicine in surgical patients. Surgery 131:3, 352-356
    CrossRef

  172. 172

    L. SALMENPERA. (2002) The use of complementary therapies among breast and prostate cancer patients in Finland. European Journal of Cancer Care 11:1, 44-50
    CrossRef

  173. 173

    Elizabeth M. Swisher, David E. Cohn, Barbara A. Goff, Judy Parham, Thomas J. Herzog, Janet S. Rader, David G. Mutch. (2002) Use of Complementary and Alternative Medicine among Women with Gynecologic Cancers. Gynecologic Oncology 84:3, 363-367
    CrossRef

  174. 174

    Andrew Sparber, Jacqueline C. Wootton. (2002) Surveys of Complementary and Alternative Medicine: Part V. Use of Alternative and Complementary Therapies for Psychiatric and Neurologic Diseases. The Journal of Alternative and Complementary Medicine 8:1, 93-96
    CrossRef

  175. 175

    C.C. Tangney, J.A. Young, M.A. Murtaugh, M.A. Cobleigh, D.M. Oleske. (2002) Self-Reported Dietary Habits, Overall Dietary Quality and Symptomatology of Breast Cancer Survivors: a Cross-Sectional Examination. Breast Cancer Research and Treatment 71:2, 113-123
    CrossRef

  176. 176

    Catherine Van Poznak, Andrew D. Seidman. 2002. Breast Cancer. , 287-299.
    CrossRef

  177. 177

    ELLEN F. HUGHES. (2001) Overview of Complementary, Alternative, and Integrative Medicine. Clinical Obstetrics and Gynecology 44:4, 774-779
    CrossRef

  178. 178

    Donna L. Richter, Sara J. Corwin, Carol E. Rheaume, Robert E. McKeown. (2001) Perceptions of Alternative Therapies Available for Women Facing Hysterectomy or Menopause. Journal of Women & Aging 13:4, 21-37
    CrossRef

  179. 179

    Judith S. Jacobson, Wendy J. Verret. (2001) Complementary and Alternative Therapy for Breast Cancer. . The Evidence So Far. Cancer Practice 9:6, 307-310
    CrossRef

  180. 180

    Abdul Rahman Jazieh, Maisaa Khalil. (2001) Hematologic Complications of Alternative Remedies. International Journal of Hematology 74:4, 405-408
    CrossRef

  181. 181

    Marian L. Neuhouser, Ruth E. Patterson, Stephen M. Schwartz, Monique M. Hedderson, Deborah J. Bowen, Leanna J. Standish. (2001) Use of Alternative Medicine by Children with Cancer in Washington State. Preventive Medicine 33:5, 347-354
    CrossRef

  182. 182

    Judith S. Jacobson, Wendy J. Verret. (2001) Complementary and Alternative Therapy for Breast Cancer. . Cancer Practice 9:6, 307-310
    CrossRef

  183. 183

    Marianne Carlsson, Maria Arman, Marie Backman, Elisabeth Hamrin. (2001) Perceived Quality of Life and Coping for Swedish Women With Breast Cancer Who Choose Complementary Medicine. Cancer Nursing 24:5, 395-401
    CrossRef

  184. 184

    (2001) Abstracts of Original Communications. Proceedings of the Nutrition Society 60:4b, 146A-170A
    CrossRef

  185. 185

    Ora Gilbar, Gidon Iron, Ayala Goren. (2001) Adjustment to illness of cancer patients treated by complementary therapy along with conventional therapy. Patient Education and Counseling 44:3, 243-249
    CrossRef

  186. 186

    M. Arman, A. Rehnsfeldt, M. Carlsson, E. Hamrin. (2001) Indications of change in life perspective among women with breast cancer admitted to complementary care. European Journal of Cancer Care 10:3, 192-200
    CrossRef

  187. 187

    Liisa Salmenperä, Tarja Suominen, Sirkka Lauri, Pauli Puukka. (2001) Attitudes of Patients With Breast and Prostate Cancer Toward Complementary Therapies in Finland. Cancer Nursing 24:4, 328-334
    CrossRef

  188. 188

    Gertraud Maskarinec, Carolyn C. Gotay, Yvonne Tatsumura, Dianne M. Shumay, Hisako Kakai. (2001) Perceived Cancer Causes. Use of Complementary and Alternative Therapy. Cancer Practice 9:4, 183-190
    CrossRef

  189. 189

    Leslie G. Bluman, Nancy A. Borstelmann, Barbara K. Rimer, J. Dirk Iglehart, Eric P. Winer. (2001) Knowledge, Satisfaction, and Perceived Cancer Risk among Women Diagnosed with Ductal Carcinoma In Situ. Journal of Women's Health & Gender-Based Medicine 10:6, 589-598
    CrossRef

  190. 190

    Edzard Ernst. (2001) Complementary therapies in palliative cancer care. Cancer 91:11, 2181-2185
    CrossRef

  191. 191

    A.Y. Rostom. (2001) The Management of Menopausal Sequelae in Patients with Breast Cancer. Clinical Oncology 13:3, 174-180
    CrossRef

  192. 192

    Andrew Sparber, Jacqueline C. Wootton. (2001) Surveys of Complementary and Alternative Medicine: Part II. Use of Alternative and Complementary Cancer Therapies. The Journal of Alternative and Complementary Medicine 7:3, 281-287
    CrossRef

  193. 193

    C Osborn. (2001) Aromatherapy: a survey of current practice in the management of rheumatic disease symptoms. Complementary Therapies in Medicine 9:2, 62-67
    CrossRef

  194. 194

    Edward Kenny, Philip R. Muskin, Richard Brown, Patricia L. Gerbarg. (2001) What the general psychiatrist should know about herbal medicine. Current Psychiatry Reports 3:3, 226-234
    CrossRef

  195. 195

    Patricia A. Burns, Nagalakshmi B. Kumar. (2001) Alternative and complementary nutritional therapies in cancer prevention and treatment: implications in clinical practice. Nutrition 17:3, 274-275
    CrossRef

  196. 196

    G. Maskarinec, S. Murphy, D.M. Shumay, H. Kakai. (2001) Dietary changes among cancer survivors. European Journal of Cancer Care 10:1, 12-20
    CrossRef

  197. 197

    Roland J. Lamarine. (2001) Alternative Medicine: More Than A Harmless Option. Journal of School Health 71:3, 114-116
    CrossRef

  198. 198

    S.K. Steginga, S. Occhipinti, J. Dunn, R.A. Gardiner, P. Heathcote, J. Yaxley. (2001) The supportive care needs of men with prostate cancer (2000). Psycho-Oncology 10:1, 66-75
    CrossRef

  199. 199

    Eric A. Jackson, Tina Kanmaz. (2001) An Overview of Information Resources for Herbal Medicinals and Dietary Supplements. Journal of Herbal Pharmacotherapy 1:1, 35-61
    CrossRef

  200. 200

    Avraham N. Kluger, Jonathan Tikochinsky. (2001) The error of accepting the "theoretical" null hypothesis: The rise, fall, and resurrection of commonsense hypotheses in psychology.. Psychological Bulletin 127:3, 408-423
    CrossRef

  201. 201

    Gertraud Maskarinec, Dianne M. Shumay, Hisako Kakai, Carolyn C. Gotay. (2000) Ethnic Differences in Complementary and Alternative Medicine Use Among Cancer Patients. The Journal of Alternative and Complementary Medicine 6:6, 531-538
    CrossRef

  202. 202

    Jacintha S. Cauffield. (2000) The Psychosocial Aspects of Complementary and Alternative Medicine. Pharmacotherapy 20:11, 1289-1294
    CrossRef

  203. 203

    Burstein, Harold J., Winer, Eric P., . (2000) Primary Care for Survivors of Breast Cancer. New England Journal of Medicine 343:15, 1086-1094
    Full Text

  204. 204

    Linda Edgar, Jean Remmer, Zeev Rosberger, Marc A. Fournier. (2000) Resource use in women completing treatment for breast cancer. Psycho-Oncology 9:5, 428-438
    CrossRef

  205. 205

    Wolfgang Sllner, Susanne Maislinger, Alexander DeVries, Eva Steixner, Gerhard Rumpold, Peter Lukas. (2000) Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior. Cancer 89:4, 873-880
    CrossRef

  206. 206

    A R P Walker. (2000) Breast cancer – can risks really be lessened?. European Journal of Cancer Prevention 9:4, 223-230
    CrossRef

  207. 207

    Kevin Murphy, Norman Delanty. (2000) Drug-Induced Seizures. CNS Drugs 14:2, 135-146
    CrossRef

  208. 208

    Harold J. Burstein. (2000) Commentary on “Internet Usage Among Women with Breast Cancer: An Exploratory Study”. Clinical Breast Cancer 1:2, 154-155
    CrossRef

  209. 209

    Katherine T Morris, Nathalie Johnson, Louis Homer, Deb Walts. (2000) A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. The American Journal of Surgery 179:5, 407-411
    CrossRef

  210. 210

    Imad Shureiqi, Pavan Reddy, Dean E Brenner. (2000) Chemoprevention: general perspective. Critical Reviews in Oncology/Hematology 33:3, 157-167
    CrossRef

  211. 211

    Janet Gulla, Adam J. Singer. (2000) Use of alternative therapies among emergency department patients. Annals of Emergency Medicine 35:3, 226-228
    CrossRef

  212. 212

    Gary D. Kao, Pamela Devine. (2000) Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer 88:3, 615-619
    CrossRef

  213. 213

    Maurie Markman. (2000) Cancer, psychologic factors, and behavior: A complex and controversial relationship. Current Oncology Reports 2:1, 2-3
    CrossRef

  214. 214

    (1999) Use of Alternative Medicine by Women with Breast Cancer. New England Journal of Medicine 341:15, 1155-1157
    Full Text

  215. 215

    Jim B Tucker. (1999) Modification of attitudes to influence survival from breast cancer. The Lancet 354:9187, 1320
    CrossRef

  216. 216

    Holland, Jimmie C., . (1999) Use of Alternative Medicine — A Marker for Distress?. New England Journal of Medicine 340:22, 1758-1759
    Full Text

Letters